ENTITY

CellSource (4880 JP)

9
Analysis
Health Care • Japan
CellSource Co., Ltd. offers regenerative medical services. The Company provides medical institution operating procedures supporting, medical expertise knowledge supporting, and other services. CellSource also operates chemical manufacturing, cell processing, and other businesses.
more
Exchange Announcement • 17 Mar 2026 15:30

Notice Regarding Approval Of Transition To The Tse Standard Market And Withdrawal Of The Plan To Meet The Continued Listing Criteria

Exchange Announcement • 17 Mar 2026 14:30

[Summary] Consolidated Financial Results For The Three Months Ended January 31, 2026 (Under Japanese Gaap)

Exchange Announcement • 09 Feb 2026 14:30

January 2026 Monthly Kpi Fiscal Year Ending October 2026

Exchange Announcement • 28 Jan 2026 14:30

Notice Regarding Application For Transition To The Tse Standard Market

Exchange Announcement • 28 Jan 2026 14:30

Regarding The Plan To Achieve Compliance With The Continued Listing Criteria

x